Shane Bobart, MD, FASN
@ShaneBobart
Followers
1K
Following
5K
Media
31
Statuses
1K
Husband, Father, Son, Nephrologist @MayoClinicNeph Florida. Liverpool FC fan. Tweets = mine and are not medical advice.
Jacksonville, FL
Joined July 2017
ASN 2025! A few quick “by the road/tubule” snapshots of our Mayo Clinic consultants. Stop by and say hi! We’re excited to meet you and collaborate!
0
3
21
A strong showing from #MayoClinicFlorida at #KidneyWeek25! Dr. LaTonya Hickson co-moderated the session “Role of the Immune System in CKD,” exploring cutting-edge research on inflammation and kidney disease. Proud to see Mayo leading in both education and scientific discovery.
0
5
14
Exciting #KidneyWeek25 sessions from #MayoClinicFlorida! 🩸 Membranous Nephropathy — Dr. Shane Bobart 🧠 Clinicopathologic Conf. 2: Nephrotic — Drs. Shane Bobart & Nelson Leung Excellence in clinical insight and scholarship! #ASN #Nephrology
0
2
9
👏 The 34th Annual Mayo Nephrology Collaborative Group Meeting at Kidney Week Dr. Julia Ingelfinger of Massachusetts General Hospital as our distinguished speaker 🎙️“A Field Guide to AI for Nephrologists – Cointelligence or Cooptation?” @LadanZand @fervenzafernan1
0
7
34
Had the privilege to hear Dr. Bobart give this amazing talk! Feels like yesterday when we wrote an IgA blog piece and rounded together. #asn #kidneyweek #gn
1
2
9
Registration is OPEN for our 3rd Annual Rare Kidney Disease Conference! 🎉 Check out our incredible faculty lineup!! we can’t wait! 😍 #RareKidney #Nephrology #MedEd For travel grants/Registration discount; DM me. 🫶🏻 https://t.co/gxJTB7lPj4
@rahaai @LLUHealth
3
10
31
Look forward to Dr. Shane Bobart's two presentations tomorrow: Membranous Nephropathy and Clinicopathologic Conference 2: Nephrotic, where Dr. Nelson Leung will take part in the discussion panel at ASN Kidney Week. #MayoClinicKidney #ASNKidneyWeek
0
8
20
We're thrilled to share the lineup of inspirational speakers set to take the stage at ASN Kidney Week on Wednesday, Nov. 5th!
0
8
19
Excited to talk about current and upcoming clinical trials in ADPKD! If interested, DM for link
2
2
30
Join our PKD team Apply now! https://t.co/Lxge8WefDM
0
5
13
Honored to present at @MayoClinic Center for Individualized Medicine Grand Rounds: “Reimagining Polycystic Kidney Disease: AI Applications, Biomarker Discovery, and Novel Therapies” #PKD #Nephrology #AI #Biomarkers #NovelTherapies
3
3
38
First @MayoClinicNeph and @vallhebron Nephrology Update. Fantastic meeting with a full house. Great organization by @PepaSolerR , @OriolBestard and all the team ! @fervenzafernan1 @JackieAR9 Thank you all!
1
9
45
It is with great gratitude that I share the news of receiving my first @NIH R01 🎉 This milestone reflects years of dedication, the support of amazing mentors, and the relentless work of the Chebib Lab. We are humbled to be stepping into the big league of science. Our mission
61
7
192
Time line of advances made in membranous nephropathy. The clinical significance of each antigen is explained. Time to diagnose, evaluate and treat MN based on the antigen. https://t.co/tgNGJJqEob
nature.com
Nature Reviews Nephrology - Since the discovery of PLA2R, several target antigens associated with membranous nephropathy have been identified. This Review describes the distinct clinical...
4
50
115
@MolnarAmber @LouiseMoist1 @charmaine_lok Editorial by @ShaneBobart and Tariq Shafi: To Shower or Not to Shower? Personal Hygiene, Safety, and Patient Choice in Hemodialysis Catheter Care https://t.co/VErbVhfNNe (FREE)
0
3
7
A few snapshots of graduation MCF 2025: Friends and colleagues celebrating the future of nephrology.
0
1
7
Congratulations to the Teacher of the Year award to Dr. Lyle Baker (General Nephrology) and Dr. Rose Mary Attieh (Transplant Nephrology)
1
4
17
Study led by former neph fellow @DrLyleBaker—alongside many of our @MayoClinic Florida neph faculty—explores #kidney outcomes in patients with advanced heart failure treated with #VADs. Completed during his #fellowship, now published in @KidneyMed! @MayoClinicNeph #NephTwitter
Kidney Outcomes in Patients With Advanced Heart Failure Treated With Ventricular Assist Devices (VADS) https://t.co/isyaFCwS6Q
0
6
12
In this multi-center study we describe 3 distinct phenotypes of patients with PLA2R-MN using unsupervised machine learning! @jingmiao2019 @fervenzafernan1 @ShaneBobart @wisit661 @PepaSolerR @NDTsocial
academic.oup.com
ABSTRACTBackground. Membranous nephropathy (MN) associated with phospholipase A2 receptor (PLA2R) antibodies is the most common cause of nephrotic syndrome
5
20
50